EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose

Christopher G Willett, Scarlett Acklin-Wehnert

Current Treatment Options in Oncology · 2024

DOI: 10.1007/s11864-024-01185-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Christopher G Willett und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Duke University Medical Center, Box 3085 Med Ctr, Durham, NC, 27710, USA. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoplasms, Second Primary. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OPINION STATEMENT: Over the past decades, the treatment of locally advanced rectal cancer has evolved dramatically due to improvements in diagnostic imaging, surgical technique, and the addition of radiotherapy and/or chemotherapy. Fractionation of neoadjuvant radiotherapy with or without concurrent chemotherapy remains the subject of discussion and the question multiple recent trials have aimed to answer. In light of recent data and concern for locoregional recurrence, our institution favors long-course chemoradiation in most cases, especially in low-lying primaries, threatened circumferential resection margin, consideration of non-operative management, or if the surgeon has concerns for resectability. Exceptions would include cases of oligometastatic disease planned for metastasectomy in which curative-intent treatment was pursued or if additional factors required a reduction in treatment time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoplasms, Second PrimaryHumansNeoadjuvant TherapyCombined Modality TherapyChemoradiotherapyNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

ChemoradiationLocally advanced rectal cancerNeoadjuvant treatmentRadiotherapyTotal neoadjuvant treatment

Autor:innen und Institutionen

  • Department of Radiation Oncology, Duke University Medical Center, Box 3085 Med Ctr, Durham, NC, 27710, USA.
  • Department of Radiation Oncology, Duke University Medical Center, Box 3085 Med Ctr, Durham, NC, 27710, USA. scarlettmarie.acklin@duke.edu.

Zitieren

APA

Willett, C. G., & Acklin-Wehnert, S. (2024). Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01185-5

Vancouver

Willett CG, Acklin-Wehnert S. Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01185-5

BibTeX
@article{Willett2024,
  author = {Willett, Christopher G and Acklin-Wehnert, Scarlett},
  title = {Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  doi = {10.1007/s11864-024-01185-5}
}
Kostenlos starten →